Continue Oral Cefalexin (Keflex)
For a patient with E. coli UTI susceptible to cefazolin who is already on cefalexin, you should continue the oral cefalexin rather than switching to IV cefazolin. The organism's susceptibility to cefazolin indicates it will respond to oral first-generation cephalosporins like cefalexin, making IV therapy unnecessary unless the patient cannot tolerate oral medications or has severe systemic illness.
Clinical Reasoning
When Oral Therapy is Appropriate
The key question is whether this patient requires parenteral therapy at all. Oral beta-lactams, including cefalexin, are appropriate for UTI treatment when the organism is susceptible, though they are considered less effective than fluoroquinolones or trimethoprim-sulfamethoxazole 1. The IDSA guidelines specifically note that oral beta-lactam agents can be used when other recommended agents cannot be employed 1.
For uncomplicated cystitis, cefalexin 50-100 mg/kg per day in 4 doses is an acceptable oral option 2, 3. For pyelonephritis, the guidelines recommend 10-14 days of therapy with a beta-lactam agent 1.
The Cefazolin-Cefalexin Relationship
Cefazolin and cefalexin are both first-generation cephalosporins with similar antimicrobial spectra. If the organism is susceptible to cefazolin (MIC ≤2 mcg/mL for systemic infections, ≤16 mcg/mL for UTI), it will respond to cefalexin 4. Recent evidence suggests that oral cephalosporins can be effective for E. coli bacteremia from urinary sources when the cefazolin MIC is favorable 5.
When to Consider IV Therapy
Switch to IV cefazolin only if:
- The patient appears toxic or septic
- The patient cannot retain oral intake or medications
- There is concern for pyelonephritis and you want to give an initial dose of long-acting parenteral therapy (1g ceftriaxone preferred over cefazolin for this indication) 1
- The patient has failed oral therapy after 48-72 hours
The IDSA guidelines specifically recommend that if an oral beta-lactam is used for pyelonephritis, an initial IV dose of a long-acting parenteral antimicrobial such as 1g ceftriaxone should be given 1. Note this recommendation is for ceftriaxone, not cefazolin.
Treatment Duration
- Uncomplicated cystitis: 7 days of cefalexin 1
- Pyelonephritis: 10-14 days of cefalexin 1, 6
- Complicated UTI: 7-14 days depending on clinical response 7
Important Caveats
Oral beta-lactams have inferior efficacy compared to fluoroquinolones and trimethoprim-sulfamethoxazole for pyelonephritis 1. If the patient has pyelonephritis and can tolerate other agents, consider switching to:
- Ciprofloxacin 500mg PO BID for 7 days (if local resistance <10%) 1
- Levofloxacin 750mg PO daily for 5 days 1
- Trimethoprim-sulfamethoxazole 160/800mg PO BID for 14 days (if susceptible) 1
Monitor clinical response at 48-72 hours. If the patient is not improving on cefalexin, reassess and consider switching to a more effective oral agent or initiating IV therapy 1.
The decision to continue oral cefalexin versus switching to IV cefazolin should be based on clinical severity, not simply on having susceptibility data. Susceptibility to cefazolin confirms that oral cefalexin is an appropriate choice 4, 5.